These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4124419)

  • 1. Comparative efficacy of sulphonamide and co-trimoxazole in urinary-tract infections in Ceylon.
    Senewiratne B; Hettiarachchi J; Senewiratne K
    Lancet; 1973 Aug; 2(7823):225-7. PubMed ID: 4124419
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriology and antibiotic sensitivity in acute urinary-tract infections in Ceylon.
    Senewiratne B; Senewiratne K; Hettiarachchi J
    Lancet; 1973 Aug; 2(7823):222-5. PubMed ID: 4124418
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of trimethoprim-sulphamethoxazole in the treatment of complicated urinary tract infection.
    Sillar S
    Aust N Z J Surg; 1972 May; 41(4):368-71. PubMed ID: 4623553
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative efficacy of sulphonamide and co-trimoxazole.
    Lacey RW; Anderson JD; Lewis EL; Gillespie WA
    Lancet; 1973 Sep; 2(7827):509. PubMed ID: 4125033
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.
    Grüneberg RN
    J Antimicrob Chemother; 1975 Sep; 1(3):305-10. PubMed ID: 1102516
    [No Abstract]   [Full Text] [Related]  

  • 6. The combination of trimethoprim and sulfamethoxazole in the treatment of urinary tract infection.
    Crichton EP; McDonnell CE
    Can Med Assoc J; 1972 Aug; 107(4):292-5. PubMed ID: 4626767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of a slow-release trimethoprim with co-trimoxazole: efficacy and selection of resistance in the Enterobacteriaceae.
    Menon R; Roberts FE; Barr KW; Howard H; Lord VL; Hegarty MA; Luxton DE; Lacey RW
    J Antimicrob Chemother; 1986 Sep; 18(3):415-20. PubMed ID: 3533889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo.
    Acar JF; Goldstein F; Chabbert YA
    J Infect Dis; 1973 Nov; 128():Suppl:470-7 p. PubMed ID: 4585953
    [No Abstract]   [Full Text] [Related]  

  • 10. Trimethoprim in the treatment and long-term control of urinary tract infection.
    Kasanen A; Toivanen P; Sourander L; Kaarsalo E; Aantaa S
    Scand J Infect Dis; 1974; 6(1):91-6. PubMed ID: 4208208
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term treatment of chronic urinary tract infections with the combination drug trimethoprim-sulfamethoxazol (Eusaprim) in chronic patients].
    Dahl S
    Z Alternsforsch; 1974; 28(3):239-45. PubMed ID: 4219513
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections.
    Lövestad A; Gästrin B; Lundström R
    Infection; 1979; 7 Suppl 4():S401-3. PubMed ID: 389814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulphamethoxazole in urinary tract infection due to Streptococcus faecalis.
    Chattopadhyay B
    J Clin Pathol; 1972 Jun; 25(6):531-3. PubMed ID: 4625437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bactrim Roche, a combination preparation of sulfamethoxazole and trimethoprim].
    Hoigné R; Müller U; Schneider HR
    Schweiz Med Wochenschr; 1969 Oct; 99(42):1511-8. PubMed ID: 4243552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs].
    Ganczarski A; Augustyniak G; Brauner G; Prelich A; Stapor K
    Przegl Lek; 1973; 30(3):303-7. PubMed ID: 4633373
    [No Abstract]   [Full Text] [Related]  

  • 16. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro sensitivity of 368 urinary organisms to trimethoprim-sulphamethoxazole and other antibacterials.
    Hunter IJ
    Med J Aust; 1970 Aug; 2(7):317-21. PubMed ID: 4319442
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment with trimethoprim-sulfamethoxazole in nonspecific urinary tract infections in pediatric urology].
    Schach H; Scheidt J; Neussel H
    Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):346-9. PubMed ID: 4563169
    [No Abstract]   [Full Text] [Related]  

  • 19. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriological evaluation of the course of urinary tract infections treated with trimethoprim and-or sulphamethoxazole.
    Knudsen JB; Korner B; Reinicke V; Stahl D; Thomsen AC
    Acta Chir Scand Suppl; 1973; 433():102-9. PubMed ID: 4575140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.